International Classification of Diseases News and Research

RSS

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Researchers compared coronavirus disease 2019 (COVID-19)-specific long-term consequences to other viral respiratory infections.

29 Dec 2022

Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

Researchers compared the prognosis of myocarditis developing after BNT162b2 mRNA COVID-19 vaccination with viral myocarditis over six months.

20 Dec 2022

Exploring COVID-19 pandemic-related increases in hospitalizations among adolescents for mental health issues

Researchers conducted a retrospective, multisite cohort study among 11 to 17-year-old adolescents in the United States of America (USA) and France.

16 Dec 2022

Data mining approaches for the detection of signals associated with pediatric post-acute sequelae of COVID-19

Researchers described tree-based scan statistics for pediatric long COVID-19.

16 Dec 2022

What is the relation between COVID-19 vaccination and new POTS-related diagnoses?

Researchers assessed the association between POTS and SARS-CoV-2 infections and COVID-19 vaccinations.

14 Dec 2022

Study of 1.1 million children finds no association between SARS-CoV-2 infection and type 1 diabetes risk

Researchers investigate whether the risk of new-onset type 1 diabetes is elevated by SARS-CoV-2 infections among children living in Denmark.

11 Dec 2022

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

Researchers evaluated individuals who had SARS-CoV-2 infections and were diagnosed with diabetes mellitus within six months of the onset of COVID-19 to understand the temporal relationship between SARS-CoV-2 infections and diabetes mellitus.

8 Dec 2022

Machine learning analysis suggests that there are four sub-phenotypes of long COVID

Researchers identified PASC [post-acute sequelae of coronavirus disease 2019 (COVID-19)] sub-phenotypes depending on conditions diagnosed within 1 to 3 months of acute infection by SARS-CoV-2.

6 Dec 2022

Monkeypox renamed "mpox" in an effort to combat stigma

WHO announces that the monkeypox virus will now be referred to as “mpox” in an effort to reduce the stigmatization of this condition.

29 Nov 2022

Males exposed to COVID-19 in utero may be at elevated risk of neurodevelopmental disorders

Researchers investigated the impact of SARS-CoV-2 exposure in utero on the neurodevelopment of children.

22 Nov 2022

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

In a recent study published in the journal BMC Medicine, researchers estimated the prevalence of new-onset diabetes following coronavirus disease 2019 (COVID-19).

21 Nov 2022

Increased distribution of fungal infections throughout the U.S.

Researchers update the geographic distribution of these species throughout the U.S.

21 Nov 2022

What is the immune protection generated by SARS-CoV-2 Delta and Omicron BA.1 and BA.2 against Omicron BA.4 and BA.5?

Researchers evaluated immune protection conferred by previous SARS-CoV-2 Delta variant and Omicron BA.1/BA.2 subvariant infections and updated vaccines against Omicron BA.4/5 infections and associated hospitalizations.

17 Nov 2022

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

In a recent study posted to the medRxiv* preprint server, researchers investigated the incidence of cardiac AESIs (adverse events of special interest) among Kaiser Permanente Northwest (KPNW) members who had received JYNNEOS vaccinations against the monkeypox (MPX) virus.

16 Nov 2022

Vitamin D can reduce severity and spread of COVID-19

In a recent study published in the Scientific Reports journal, researchers in the United States assessed the relationship between supplementation with vitamin D and coronavirus disease 2019 (COVID-19) and related mortality.

15 Nov 2022

Do SSRIs lower the risk of long COVID?

Researchers conducted a retrospective study to determine whether SSRIs with immunomodulatory and antiplatelet properties can decrease the risk of post-acute sequelae of COVID-19 (PASC).

15 Nov 2022

The comparative risk of myocarditis, pericarditis, and myopericarditis between BNT162b2 and mRNA-1273 second doses

Researchers assessed the risk of myocarditis or pericarditis after the COVID-19 mRNA vaccine second doses.

10 Nov 2022

Italian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individuals

Researchers from Italy investigated the risk of SARS-CoV-2 reinfection and hospitalization among individuals with vaccinations and previous SARS-CoV-2 infections.

31 Oct 2022

The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis

A new study aimed to analyze the association between lifestyle risk factors, PRSs, and their interactions along with the risk of CVE within 90 days post-COVID-19 diagnosis.